Activity
Mon
Wed
Fri
Sun
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
What is this?
Less
More

Owned by Anthony

Where science meets results. Learn peptides, training, recovery & more. No ego, no fluff—just smarter bodies, better minds, built to adapt.

435 contributions to Castore: Built to Adapt
Free live session, Wed Dec 9: Find Your First Move
Most questions I get are some version of this: what dose, which compound, how do I cycle it. Underneath almost every one is a different question. Why am I not getting the result I want, and is this the thing I'm missing? On Wednesday, December 9 at 5 PM Eastern, I'm answering that question live, on real situations, for one hour. It's free and open to everyone in this community. How it works: - Three volunteers tell me what they're doing: training, food, sleep, supplements, peptides, all of it. - I place each one on the pyramid and walk through the first move I'd make, what I'd leave alone, and how we'd know it was working. - You watch the reasoning, so you can run the same read on yourself or the people you coach. Want to be one of the three? Comment below with your goal and the one thing that isn't working. I'll pick three situations that differ from each other so everyone learns something. In the last few minutes I'll share what's coming in January for anyone who wants to go deeper. Register here: https://us06web.zoom.us/meeting/register/HvyKXKnTQIy48E98JSu8Nw I'll post the recording here afterward. This is teaching. I'm not a physician, I don't prescribe, and nothing in the session is individual medical direction.
1
0
ATX Sodium Salt
Hey @Anthony Castore i recently heard on a podcast there are a couple different versions of atx304 out there. Can you explain the sodium salt vs the other version(s)? Dosage differences? And also maybe what we can look for on a COA or a research website to differentiate? Seems like some websites list it explicitly and others are more vague. Thanks so much !
1 like • 1d
The original human study used the plain, non-salt form of ATX-304. It was called O304 at the time. In the 2018 TELLUS study, people with type 2 diabetes who were already taking metformin received 1,000 mg a day as a liquid suspension. A later study used a 400 mg sodium-salt tablet once a day in people with obesity and prediabetes. There’s also a potassium salt in the animal research. I haven’t seen human dosing data for that one. With the sodium salt, you have the same parent molecule paired with sodium. That can change how it dissolves and how much reaches the bloodstream. Even a tablet and a capsule made with the sodium salt produced different blood levels in the developer’s research. So I wouldn’t use those two studies to say 400 mg of one equals 1,000 mg of the other. The part I’d back up to is the word “bioavailability.” It’s easy to hear “better absorbed” and jump straight to wanting the newer version. I’d first want to know what we’re asking this molecule to do. ATX-304 is being studied for its effects on AMPK, one of the ways a cell senses energy demand and adjusts how it uses fuel. If somebody consistently has elevated fasting glucose and poor glucose tolerance, I can see why the research caught their attention. We have something measurable to follow. If a lean athlete tells me they feel flat halfway through training, I’m going to ask what they ate, how they slept, and what training looked like that week. Feeling flat gives me very little reason to think they need more AMPK signaling. The way you’d test the absorption claim is to compare blood levels over time after giving equivalent amounts of the parent molecule in each formulation. Then I’d want to know whether the group with higher blood levels actually had better glucose control. That second question is the one I care about as a coach. On the website side, if all it says is “ATX-304,” I’d call the form unspecified. And a COA, or certificate of analysis, is a pretty small piece of the picture. Here’s what I’d ask:
SS-31 (elamipretide) + PQQ + CoQ10 + NR/NMN Protocol
@Anthony Castore Recently saw something on SS-31 protocol and adding oral PQQ, CoQ10, plus oral NAD+ precursors so thought would share and why adding these oral supplements in addition might be beneficial. I'd like to hear thoughts of others. Combining SS-31, CoQ10, and PQQ creates a powerful triple-action synergy for a full-spectrum mitochondrial reset. When you stack them, they address three distinct pillars of cellular health simultaneously: structural protection, energetic fuel, and system expansion. The multi-layered synergy works through a step-by-step process inside the cells: Before your cells can efficiently build or fuel energy, they need stable scaffolding. - SS-31 targets the inner mitochondrial membrane and binds to cardiolipin. - By stabilizing this membrane, SS-31 physically repairs the "factory floor". - This structural optimization ensures that the electron transport chain is perfectly aligned, creating an optimal environment for CoQ10 and PQQ to do their jobs. With the factory stabilized by SS-31, CoQ10 can work at maximum efficiency. - CoQ10 shuttles the electrons through the newly stabilized membrane to generate ATP. - Crucially, PQQ directly regenerates used CoQ10 back into its active antioxidant form (ubiquinol). This creates a direct chemical loop: PQQ recycles CoQ10, keeping the electron delivery system running continuously without burning out. While SS-31 repairs existing structures and CoQ10 fuels them, PQQ ensures you don't run out of capacity. - PQQ triggers the master switch (PGC-1α) to replicate mitochondrial DNA and generate brand-new organelles. - As PQQ creates these new mitochondria, SS-31 is available to properly structure their inner membranes, and CoQ10 is waiting to fuel their electron transport chains right from the start. Instead of just increasing energy output (CoQ10) or just building new cells (PQQ), adding SS-31 ensures that your existing and newly created mitochondria are physically healthy, structurally sound, and protected against oxidative stress. Longevity researchers and advanced biohackers often refer to this trio as a comprehensive "mitochondrial longevity stack.
1 like • 4d
There’s a reasonable rationale for combining some of these, but I’d separate complementary biology from demonstrated synergy. “Full-spectrum mitochondrial reset” gets ahead of what we can establish. I didn’t find a controlled human study testing this complete combination. The question I’d start with is, what is actually limiting energy production? Adding more components helps most when those components address a real limitation. SS-31 is the strongest part of the structural argument. It interacts with cardiolipin, a lipid in the inner mitochondrial membrane that helps organize energy-producing machinery. Experimental work shows that it can protect the cardiolipin–cytochrome c interaction and support electron transfer. But “physically repairs the factory floor” and “perfectly aligns the electron transport chain” imply a completeness we haven’t demonstrated. The human endpoints matter here too. One small randomized study in older adults found an acute improvement in one measure of mitochondrial energetic capacity, without improved fatigue resistance. A larger trial in primary mitochondrial myopathy did not meet its primary walking-distance or fatigue endpoints. Those findings don’t erase the mechanism; they show why mechanism and meaningful benefit need separate evaluation. CoQ10 is an electron carrier, rather than fuel. It accepts electrons from Complex I, Complex II, and other entry points, then transfers them toward Complex III. Both ubiquinone and ubiquinol are functional parts of that cycle. Oxidized CoQ10 isn’t “used up”; accepting and releasing electrons is its job. That’s why I’d revisit the claim that PQQ directly regenerates CoQ10 and keeps the system running continuously. PQQ has interesting redox chemistry, but I couldn’t verify that specific recycling loop as an established effect of oral supplementation in human mitochondria. And swallowing more CoQ10 doesn’t guarantee more reaches the relevant tissue. A recent randomized trial in older adults increased plasma CoQ10 without increasing muscle mitochondrial CoQ10 or improving mitochondrial function. That’s one population and exposure, but it’s an important delivery limitation.
MotC with a GHRH/GHRP
MotC with a GHRH/GHRP. Be useful or beneficial since it impairs some regenerative functions ? tissue repair is not simply a matter of maximizing AMPK or mTOR activity. Different cells require different balances of energy conservation, proliferation, inflammation and matrix remodeling. From the studies I have read , it has been shown some regenerative functions were impaired despite metabolic signaling changes. The study I am referencing too : https://pubmed.ncbi.nlm.nih.gov/42324588/
1 like • 4d
I think there’s a reasonable hypothesis for combining MOTS-c with a GHRH/GHRP, but I’d be careful about using this paper to argue either for or against it. The first thing I’d revisit is what they actually tested, human fat-derived stromal cells exposed to one concentration of MOTS-c for 48 hours, then transplanted into mice with kidney injury. That’s a pretty specific experiment to translate into “MOTS-c impairs regeneration.” The endpoints matter too. They found unfavorable effects on some repair measures, but some oxygenation findings were favorable. Blood flow, oxygenation, fibrosis, and tissue injury each tell us something different. We need to keep those findings separate. I’d also want to inspect the direct comparisons. If untreated cells significantly improve an endpoint versus control and treated cells don’t, that alone doesn’t prove the treatment impaired repair. The two treatment groups need to differ directly. With six donors and six mice per group, I’d want replication, different concentrations, and different exposure durations before making a broad claim. Increased p16/p21 expression raises a question about senescence, but doesn’t establish permanent loss of repair capacity. And the study didn’t demonstrate that AMPK caused the unfavorable effects. A GHRH/GHRP can increase GH release, and GH has evidence for increasing collagen synthesis. That makes complementary effects plausible. It doesn’t establish that adding a growth signal corrects the cellular changes seen here. My take is that this study raises a useful question about exposure and cellular context. It doesn’t settle whether systemic MOTS-c compromises human tissue repair, and it doesn’t tell us whether this combination helps. I’d keep the combination as a hypothesis and judge it by actual tissue function rather than assuming the signaling balances itself out.
ATX-304 vs. MOTS-c: The pathway matters. The person matters more.
Two people walk into a consultation and tell me the same thing.“My energy is terrible.” The first has elevated glucose, excess body fat and evidence of insulin resistance. There is plenty of stored energy, but regulating and using that fuel may be part of the problem. The second is lean, training hard, sleeping five hours a night and cutting calories because they want to get leaner. Same complaint. Very different circumstances. If I hear “low energy” and immediately reach for an AMPK activator, I’ve skipped the part that determines whether my reasoning makes sense. What is actually limiting this person? That’s the conversation I want to have about ATX-304 and MOTS-c. Both connect to AMPK, but they reach it differently. Understanding those differences gets us much further than deciding which one sounds more powerful. Let’s begin with the cell’s energy conversation. ATP is the cell’s immediately usable energy currency. When ATP is spent, ADP and AMP help communicate changes in energy availability. AMPK helps respond to that information. It can adjust fuel handling and shift the balance between processes that consume energy and those that help restore it. Think about what you do when expenses rise faster than income. You look for ways to bring more in and become more selective about where it goes. Cells do something similar. But AMPK is not one simple on/off button. It’s a three-part complex. The alpha subunit does the catalytic work. The gamma subunit helps sense energy status by binding molecules such as AMP, ADP and ATP. The beta subunit helps hold the complex together and contributes to its regulation. For this comparison, remember two things: an energy-sensing component and an activating phosphate on the working component. That phosphate sits at a site called Thr172. That’s simply the threonine building block at position 172 on AMPK’s alpha subunit. Think of the phosphate as a tag attached at that location. Now we can see where the two compounds differ. ATX-304 helps preserve an active instruction.
0 likes • 5d
The part I’d revisit first is the six hours. There’s newer stuff showing nearly a four-day half-life for ATX-304. So yesterday’s dose is still very much part of today’s conversation. That doesn’t mean AMPK stays equally elevated for four days or that muscle growth gets put on hold. Half-life tells us how slowly the body clears the drug. How strongly it affects a pathway, in which tissue, and for how long are separate questions. The small human study reporting that half-life used daily dosing in people with obesity and prediabetes. Levels accumulated over approximately three weeks, with relatively little fluctuation between doses. That makes it difficult to argue that moving it a few hours away from training creates a clean separation. On the AMPK–mTOR side, you need both working together to adapt. AMPK helps coordinate fuel availability and energy use. mTOR, particularly the group of proteins called mTORC1, helps coordinate building new proteins when the conditions support it. Building muscle costs energy. AMPK helps the cell match what it spends with what it can supply. When energy stress is substantial, AMPK can apply brakes to mTORC1 through regulatory proteins called TSC2 and raptor. But how much braking occurs depends on the strength and duration of the signal, the tissue, and the resources available. We have human research where interval cycling increased AMPK activity, yet the muscle retained its mTORC1-related response to lifting afterward. That doesn’t establish that prolonged drug exposure behaves the same way. It does show why “AMPK went up, so growth shut down” skips several steps. With ATX, early experiments showed that it helps preserve a chemical tag that keeps AMPK active. That supports a sustained signal, but we still don’t know precisely how that translates into muscle protein synthesis in trained humans. The uncoupling adds another piece. Your mitochondria use energy from food to push positively charged particles called protons across a membrane. When those protons flow back through ATP synthase, that machinery makes ATP, the energy molecule your cells spend to do their work. I would think about water held behind a dam and getting directed through a turbine. With uncoupling, some water takes a route around the turbine. Some energy gets released as heat, and the mitochondria may process more fuel and consume more oxygen to maintain ATP production.
1-10 of 435
Anthony Castore
7
2,425 points to level up
@anthony-castore-4271
Anthony Castore — SSRP Fellow & strength coach blending peptides, training, and cellular medicine to optimize performance and recovery.

Active 4h ago
Joined Jul 31, 2025
Powell, OH
Powered by